Legal & General Group
HBIO icon

Legal & General Group’s Harvard Bioscience HBIO Stock Holding History

Legal & General Group’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-379
Closed -$2.14K – 3464
2025
Q1 		$2.14K Hold
379
– – ﹤0.01% 3350
2024
Q4 		$7.94K Hold
379
– – ﹤0.01% 3290
2024
Q3 		$10.2K Hold
379
– – ﹤0.01% 3267
2024
Q2 		$10.8K Sell
379
-63
-14% -$2.21K ﹤0.01% 3283
2024
Q1 		$18.7K Hold
442
– – ﹤0.01% 2992
2023
Q4 		$23.6K Buy
442
+40
+10% +$1.81K ﹤0.01% 2967
2023
Q3 		$17.3K Sell
402
-71
-15% -$3.28K ﹤0.01% 3093
2023
Q2 		$26K Buy
+473
New +$26K ﹤0.01% 3003
2022
Q2 		– Sell
-385
Closed -$24K – 3580
2022
Q1 		$24K Hold
385
– – ﹤0.01% 3188
2021
Q4 		$27K Hold
385
– – ﹤0.01% 3185
2021
Q3 		$27K Hold
385
– – ﹤0.01% 3165
2021
Q2 		$32K Buy
385
+52
+16% +$3.68K ﹤0.01% 3111
2021
Q1 		$18K Hold
333
– – ﹤0.01% 3170
2020
Q4 		$14K Hold
333
– – ﹤0.01% 3219
2020
Q3 		$10K Sell
333
-145
-30% -$4.88K ﹤0.01% 3232
2020
Q2 		$15K Buy
+478
New +$12.9K ﹤0.01% 3181
2019
Q3 		– Sell
-523
Closed -$10K – 3382
2019
Q2 		$10K Hold
523
– – ﹤0.01% 3357
2019
Q1 		$23K Hold
523
– – ﹤0.01% 3044
2018
Q4 		$17K Hold
523
– – ﹤0.01% 3142
2018
Q3 		$27K Hold
523
– – ﹤0.01% 3076
2018
Q2 		$28K Buy
+523
New +$26.8K ﹤0.01% 3051

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Legal & General Group's HBIO Position: Q2 2025 in Review

Legal & General Group sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 379 shares — an estimated $2.14K sold.

Legal & General Group first reported a position in HBIO in Q2 2018 and held it in 21 quarters. The position peaked at $32K in Q2 2021. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

  • Legal & General Group reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 379 Harvard Bioscience shares in Q2 2025, an estimated $2.14K.
  • Legal & General Group first reported a position in Harvard Bioscience in Q2 2018 and held it in 21 quarters.
  • Legal & General Group's Harvard Bioscience position peaked at $32K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.